Asset Details
Do you wish to reserve the book?
A one health perspective on multidrug-resistant bacterial infections: integrated approaches for surveillance, policy and innovation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A one health perspective on multidrug-resistant bacterial infections: integrated approaches for surveillance, policy and innovation
Do you wish to request the book?
A one health perspective on multidrug-resistant bacterial infections: integrated approaches for surveillance, policy and innovation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A one health perspective on multidrug-resistant bacterial infections: integrated approaches for surveillance, policy and innovation
2025
Overview
Multidrug-resistant (MDR) bacterial infections represent a growing global health emergency, driven by interconnected human, animal, and environmental factors. This review adopts a One Health perspective to explore the transmission dynamics, operational integration, and innovative responses to antimicrobial resistance (AMR). Case studies from China, India, Nigeria, Thailand, and Brazil underscore the effectiveness of regulatory reforms, surveillance networks, and public engagement campaigns. Notably, Artificial Intelligence (AI) is transforming MDR management through real-time diagnostics and resistance prediction, though ethical concerns and infrastructure deficits in Low- and Middle-Income Countries (LMICs) remain barriers. Community-led initiatives, gender-sensitive education, and policy reforms are vital to curbing misuse and closing equity gaps. Despite successes, challenges such as fragmented governance, underfunded labs, and limited longitudinal research persist. A proactive, integrated One Health approach—linking clinical, environmental, and policy actions—is essential for reducing MDR burden. Investment in intersectoral surveillance, equitable AI deployment, and community empowerment is imperative for safeguarding antibiotics and ensuring global health resilience.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Animals
/ Anti-Bacterial Agents - pharmacology
/ Anti-Bacterial Agents - therapeutic use
/ Bacteria
/ Bacterial Infections - diagnosis
/ Bacterial Infections - drug therapy
/ Bacterial Infections - epidemiology
/ Bacterial Infections - microbiology
/ Bacterial Infections - prevention & control
/ Bacterial Infections - transmission
/ Cellular and Infection Microbiology
/ Drug Resistance, Multiple, Bacterial
/ Humans
/ inter-sectoral collaborations
/ Multidrug resistant organisms
/ multidrug-resistant (MDR) bacteria
/ Runoff
